The study of efficacy and complications of uterine artery embolization in patients with symptomatic uterine fibroids
Not Applicable
- Conditions
- utrine fibroids and bleeding.Other specified noninflammatory disorders of uterus
- Registration Number
- IRCT2014012714333N16
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 97
Inclusion Criteria
written consent of the patient; women with symptomatic uterine fibroids; candidate of hysterectomy or myomectomy. Exclusion criteria: no menopause, ovarian tumors.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Type of fibroids. Timepoint: Baseline and 3, 6 and 12 months after embolization (UAE). Method of measurement: MRI.;Uterine size. Timepoint: Baseline and 3, 6 and 12 months after embolization (UAE). Method of measurement: Sonography.;Clinical symptoms. Timepoint: 3, 6 and 12 months after embolization (UAE). Method of measurement: Based on questionnaire.;Fibroid size. Timepoint: Baseline and 3, 6 and 12 months after embolization (UAE). Method of measurement: MRI.;Permanent amenorrhea. Timepoint: Baseline and 3, 6 and 12 months after embolization (UAE). Method of measurement: Asking the patient.;Continuous vaginal discharge. Timepoint: 3, 6 and 12 months after embolization (UAE). Method of measurement: Asking the patient.;Recurrence of fibroids. Timepoint: 3, 6 and 12 months after embolization (UAE). Method of measurement: MRI.
- Secondary Outcome Measures
Name Time Method